World Journal of Laparoscopic Surgery

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  18 (2025)
Volume  17 (2024)
Volume  16 (2023)
Volume  15 (2022)
Volume  14 (2021)
Volume  13 (2020)
Volume  12 (2019)
Volume  11 (2018)
Volume  10 (2017)
Volume  9 (2016)
Volume  8 (2015)
Volume  7 (2014)
Volume  6 (2013)
Volume  5 (2012)
Volume  4 (2011)
Volume  3 (2010)
Volume  2 (2009)
Volume  1 (2008)
Related articles

VOLUME 16 , ISSUE 1 ( January-April, 2023 ) > List of Articles

CASE REPORT

Pulmonary Thromboembolism While Receiving Tranexamic Acid after Laparotomy Myomectomy: A Case Report

Shahla Noori Ardabili, Atefeh Zeinali, Rajneesh Kumar Mishra, Samaneh Chegeni, Ali Mehrafshar, Nooshin Noori

Keywords : Case report, Pulmonary embolism, Thromboembolism, Tranexamic acid

Citation Information : Ardabili SN, Zeinali A, Mishra RK, Chegeni S, Mehrafshar A, Noori N. Pulmonary Thromboembolism While Receiving Tranexamic Acid after Laparotomy Myomectomy: A Case Report. World J Lap Surg 2023; 16 (1):52-53.

DOI: 10.5005/jp-journals-10033-1549

License: CC BY-NC 4.0

Published Online: 05-09-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Abstract

Aim: We aimed to review a case with pulmonary thromboembolism while using tranexamic acid after laparotomy myomectomy. Background: Pulmonary embolism (PE) is life-threatening and early diagnosis and proper treatment are crucial. Case description: This case was a middle-aged healthy and active woman that referred to our gynecology clinic due to menometrorrhagia and dysmenorrhea. According to an ultrasound report, she had an enlarged myxomatosis uterus. Medical treatment did not work therefore she chose the surgery. During surgery due to massive blood loss, 1 gram of tranexamic acid was infused two packed cells were transfused. After 48 hours of the surgery, the patient complained of shortness of breath. More evaluations showed PE. The patient had no thromboembolism risk factors. It seemed that tranexamic acid caused thrombosis in this patient. After proper treatment measures such as anticoagulant medicines, she was discharged from the hospital. Clinical significance: Considering the risk of thrombosis in each case as prescribed tranexamic acid.

HTML PDF Share
  1. Tapson VF. Acute pulmonary embolism. N Engl J Med 2008;358(10):1037–1052. DOI: 10.1056/NEJMra072753.
  2. Khademvatani K, Rezaei Y, Kerachian A, et al. Acute pulmonary embolism caused by enlarged uterine leiomyoma: a rare presentation. Am J Case Rep 2014;15:300–303. DOI: 10.12659/AJCR.890607.
  3. Lawson JH, Murphy MP. Challenges for providing effective hemostasis in surgery and trauma. Semin Hematol 2004;41(1 Suppl 1):55–64. DOI: 10.1053/j.seminhematol.2003.11.012.
  4. Gofur N, Gofur A, Soesilaningtyas GA, et al. Uterine myoma, risk factor and pathophysiology: A review article. Clinics of Oncology 2021;4(3):1–4.
  5. Wallach EE, Buttram Jr VC, Reiter RC. Uterine leiomyomata: Etiology, symptomatology, and management. Fertil Steril 1981;36(4):433–445. DOI: 10.1016/s0015-0282(16)45789-4.
  6. Farrer‐Brown G, Beilby J, Tarbit M. The vascular patterns in myomatous uteri. BJOG: An International Journal of Obstetrics & Gynaecology 1970;77(11):967–975. DOI: https://doi.org/10.1111/j.1471-0528.1970.tb03439.x.
  7. Okolo S. Incidence, aetiology and epidemiology of uterine fibroids. Best Pract Res Clin Obstet Gynaecol 2008;22(4):571–588. DOI: 10.1016/j.bpobgyn.2008.04.002.
  8. Vollenhoven BJ, Lawrence AS, Healy DL. Uterine fibroids: A clinical review. Br J Obstet Gynaecol. 1990;97(4):285–298. DOI: 10.1111/j.1471-0528.1990.tb01804.x.
  9. Pabinger I, Fries D, Schöchl H et al. Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis. Wien Klin Wochenschrrift 2017;129(9):303–316. DOI: 10.1007/s00508-017-1194-y.
  10. Reed MR, Woolley LT. Uses of tranexamic acid. Continuing Education in Anaesthesia, Critical Care and Pain 2015;15(1):32–37. DOI: https://doi.org/10.1093/bjaceaccp/mku009.
  11. Smith SB, Geske JB, Maguire JM, et al. Early anticoagulation is associated with reduced mortality for acute pulmonary embolism. Chest 2010;137(6):1382–1390. DOI: 10.1378/chest.09-0959.
  12. Sundström A, Seaman H, Kieler H, et al. The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: A case–control study using the General Practice Research Database. BJOG: An International Journal of Obstetrics & Gynaecology 2009;116(1):91–97. DOI: 10.1111/j.1471-0528.2008.01926.x.
  13. Klaassen R, Selles C, van den Berg J, et al. Tranexamic acid therapy for postoperative bleeding after bariatric surgery. BMC Obes 2018;5(1):1–6.
  14. Shiraishi A, Kushimoto S, Otomo Y, et al. Effectiveness of early administration of tranexamic acid in patients with severe trauma. Journal of British Surgery 2017;104(6):710–717. DOI: 10.1002/bjs.10497.
  15. Krivokuca I, Lammers J-W. Recurrent pulmonary embolism associated with a hemostatic drug: Tranexamic acid. Clin Appl Thromb Hemost 2011;17(1):106–107. DOI: 10.1177/1076029609340902.
  16. Salam A, King C, Orhan O, et al. The great deception: tranexamic acid and extensive pulmonary emboli. BMJ Case Reports 2013;2013:bcr2012007808. DOI: 10.1136/bcr-2012-007808.
  17. Morrison JJ, Dubose JJ, Rasmussen TE, et al. Military application of tranexamic acid in trauma emergency resuscitation (MATTERs) study. Arch Surg 2012;147(2):113–119. DOI: 10.1001/archsurg.2011.287.
  18. Wiysonge CS, Kongnyuy E. Interventions to reduce haemorrhage duringmyomectomy for fibroids. Cochrane Database Syst Rev 2014;2014(8):CD005355. DOI: 10.1002/14651858.CD005355.pub5.
  19. Nicolaides A, Fareed J, Kakkar A, et al. Prevention and treatment of venous thromboembolism: International consensus statement (guidelines according to scientific evidence). International angiology 2006;25(2):101. DOI: https://doi.org/10.1177/1076029612474840.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.